ProPhase Labs, Inc.·4

Mar 19, 9:52 PM ET

Latkin Jed 4

4 · ProPhase Labs, Inc. · Filed Mar 19, 2024

Insider Transaction Report

Form 4
Period: 2024-01-01
Latkin Jed
Director
Transactions
  • Award

    Option (right to buy)

    2024-01-01+500,000500,000 total
    Exercise: $6.00Exp: 2031-01-01Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]The option vests over a three year period, with 25% vesting on the date of grant and 25% vesting on each anniversary thereafter, subject to the Reporting Person's continued service through each vesting date

Documents

1 file
  • 4
    ownership.xmlPrimary